Near-Patient Molecular Solutions Global Market Report 2025
Description
Near-Patient Molecular Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on near-patient molecular solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for near-patient molecular solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The near-patient molecular solutions market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product Type: Infectious Diseases Testing Kits; Urinalysis Testing Kits; Tumor Or Cancer Markers; Pregnancy And Fertility; Hematology Testing Kits; Glucose Monitoring Kits; Drugs-Of-Abuse Testing Kits; Coagulation Monitoring Kits; Cardiometabolic Monitoring Kits; Other Product Types
2) By Technology: Polymerase Chain Reaction (PCR)-Based; Genetic Sequencing-Based; Hybridization-Based; Microarray-Based
3) By End-User: Hospitals And Clinics; Ambulatory Care Centers; Research Laboratories; Home Care Settings; Other End-Users
Subsegments:
1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits; Human Immunodeficiency Virus Testing Kits; Influenza Testing Kits; COVID-19 Testing Kits
2) By Urinalysis Testing Kits: Protein Testing Kits; Glucose Testing Kits; Ketone Testing Kits; Nitrite Testing Kits
3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits; Carcinoembryonic Antigen Testing Kits; Cancer Antigen 125 Testing Kits; Alpha-Fetoprotein Testing Kits
4) By Pregnancy And Fertility: Ovulation Testing Kits; Early Pregnancy Testing Kits; Digital Pregnancy Testing Kits; Home Fertility Monitoring Kits
5) By Hematology Testing Kits: Complete Blood Count Testing Kits; Hemoglobin Testing Kits; White Blood Cell Count Testing Kits; Platelet Count Testing Kits
6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits; Continuous Glucose Monitoring Kits; Non-Invasive Glucose Testing Kits; Disposable Glucose Test Strips
7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits; Saliva Drug Testing Kits; Hair Drug Testing Kits; Blood Drug Testing Kits
8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits; International Normalized Ratio Testing Kits; Activated Partial Thromboplastin Time Testing Kits; D-Dimer Testing Kits
9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits; Triglyceride Testing Kits; Low-Density Lipoprotein Testing Kits; High-Density Lipoprotein Testing Kits
10) By Other Product Types: Allergy Testing Kits; Thyroid Function Testing Kits; Vitamin Deficiency Testing Kits; Liver Function Testing Kits
Companies Mentioned: Bosch Healthcare Solutions GmbH; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Hologic Inc.; bioMérieux SA; Sysmex Corporation; QuidelOrtho Corporation; QIAGEN NV; DiaSorin SpA; OraSure Technologies Inc.; Molbio Diagnostics Pvt Ltd; Cue Health Inc.; Biocartis Group NV; Vela Diagnostics Pte Ltd; Co-Diagnostics Inc.; Hyris Ltd; Genedrive plc.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on near-patient molecular solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for near-patient molecular solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The near-patient molecular solutions market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product Type: Infectious Diseases Testing Kits; Urinalysis Testing Kits; Tumor Or Cancer Markers; Pregnancy And Fertility; Hematology Testing Kits; Glucose Monitoring Kits; Drugs-Of-Abuse Testing Kits; Coagulation Monitoring Kits; Cardiometabolic Monitoring Kits; Other Product Types
2) By Technology: Polymerase Chain Reaction (PCR)-Based; Genetic Sequencing-Based; Hybridization-Based; Microarray-Based
3) By End-User: Hospitals And Clinics; Ambulatory Care Centers; Research Laboratories; Home Care Settings; Other End-Users
Subsegments:
1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits; Human Immunodeficiency Virus Testing Kits; Influenza Testing Kits; COVID-19 Testing Kits
2) By Urinalysis Testing Kits: Protein Testing Kits; Glucose Testing Kits; Ketone Testing Kits; Nitrite Testing Kits
3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits; Carcinoembryonic Antigen Testing Kits; Cancer Antigen 125 Testing Kits; Alpha-Fetoprotein Testing Kits
4) By Pregnancy And Fertility: Ovulation Testing Kits; Early Pregnancy Testing Kits; Digital Pregnancy Testing Kits; Home Fertility Monitoring Kits
5) By Hematology Testing Kits: Complete Blood Count Testing Kits; Hemoglobin Testing Kits; White Blood Cell Count Testing Kits; Platelet Count Testing Kits
6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits; Continuous Glucose Monitoring Kits; Non-Invasive Glucose Testing Kits; Disposable Glucose Test Strips
7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits; Saliva Drug Testing Kits; Hair Drug Testing Kits; Blood Drug Testing Kits
8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits; International Normalized Ratio Testing Kits; Activated Partial Thromboplastin Time Testing Kits; D-Dimer Testing Kits
9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits; Triglyceride Testing Kits; Low-Density Lipoprotein Testing Kits; High-Density Lipoprotein Testing Kits
10) By Other Product Types: Allergy Testing Kits; Thyroid Function Testing Kits; Vitamin Deficiency Testing Kits; Liver Function Testing Kits
Companies Mentioned: Bosch Healthcare Solutions GmbH; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Hologic Inc.; bioMérieux SA; Sysmex Corporation; QuidelOrtho Corporation; QIAGEN NV; DiaSorin SpA; OraSure Technologies Inc.; Molbio Diagnostics Pvt Ltd; Cue Health Inc.; Biocartis Group NV; Vela Diagnostics Pte Ltd; Co-Diagnostics Inc.; Hyris Ltd; Genedrive plc.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Near-Patient Molecular Solutions Market Characteristics
- 3. Near-Patient Molecular Solutions Market Trends And Strategies
- 4. Near-Patient Molecular Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Near-Patient Molecular Solutions Growth Analysis And Strategic Analysis Framework
- 5.1. Global Near-Patient Molecular Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Near-Patient Molecular Solutions Market Growth Rate Analysis
- 5.4. Global Near-Patient Molecular Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Near-Patient Molecular Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Near-Patient Molecular Solutions Total Addressable Market (TAM)
- 6. Near-Patient Molecular Solutions Market Segmentation
- 6.1. Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Infectious Diseases Testing Kits
- Urinalysis Testing Kits
- Tumor Or Cancer Markers
- Pregnancy And Fertility
- Hematology Testing Kits
- Glucose Monitoring Kits
- Drugs-Of-Abuse Testing Kits
- Coagulation Monitoring Kits
- Cardiometabolic Monitoring Kits
- Other Product Types
- 6.2. Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymerase Chain Reaction (PCR)-Based
- Genetic Sequencing-Based
- Hybridization-Based
- Microarray-Based
- 6.3. Global Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Ambulatory Care Centres
- Research Laboratories
- Home Care Settings
- Other End-Users
- 6.4. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hepatitis Testing Kits
- Human Immunodeficiency Virus Testing Kits
- Influenza Testing Kits
- COVID-19 Testing Kits
- 6.5. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Protein Testing Kits
- Glucose Testing Kits
- Ketone Testing Kits
- Nitrite Testing Kits
- 6.6. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prostate-Specific Antigen Testing Kits
- Carcinoembryonic Antigen Testing Kits
- Cancer Antigen 125 Testing Kits
- Alpha-Fetoprotein Testing Kits
- 6.7. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ovulation Testing Kits
- Early Pregnancy Testing Kits
- Digital Pregnancy Testing Kits
- Home Fertility Monitoring Kits
- 6.8. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Complete Blood Count Testing Kits
- Hemoglobin Testing Kits
- White Blood Cell Count Testing Kits
- Platelet Count Testing Kits
- 6.9. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Self-Monitoring Blood Glucose Kits
- Continuous Glucose Monitoring Kits
- Non-Invasive Glucose Testing Kits
- Disposable Glucose Test Strips
- 6.10. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Urine Drug Testing Kits
- Saliva Drug Testing Kits
- Hair Drug Testing Kits
- Blood Drug Testing Kits
- 6.11. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prothrombin Time Testing Kits
- International Normalized Ratio Testing Kits
- Activated Partial Thromboplastin Time Testing Kits
- D-Dimer Testing Kits
- 6.12. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cholesterol Testing Kits
- Triglyceride Testing Kits
- Low-Density Lipoprotein Testing Kits
- High-Density Lipoprotein Testing Kits
- 6.13. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Allergy Testing Kits
- Thyroid Function Testing Kits
- Vitamin Deficiency Testing Kits
- Liver Function Testing Kits
- 7. Near-Patient Molecular Solutions Market Regional And Country Analysis
- 7.1. Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Near-Patient Molecular Solutions Market
- 8.1. Asia-Pacific Near-Patient Molecular Solutions Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Near-Patient Molecular Solutions Market
- 9.1. China Near-Patient Molecular Solutions Market Overview
- 9.2. China Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Near-Patient Molecular Solutions Market
- 10.1. India Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Near-Patient Molecular Solutions Market
- 11.1. Japan Near-Patient Molecular Solutions Market Overview
- 11.2. Japan Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Near-Patient Molecular Solutions Market
- 12.1. Australia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Near-Patient Molecular Solutions Market
- 13.1. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Near-Patient Molecular Solutions Market
- 14.1. South Korea Near-Patient Molecular Solutions Market Overview
- 14.2. South Korea Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Near-Patient Molecular Solutions Market
- 15.1. Western Europe Near-Patient Molecular Solutions Market Overview
- 15.2. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Near-Patient Molecular Solutions Market
- 16.1. UK Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Near-Patient Molecular Solutions Market
- 17.1. Germany Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Near-Patient Molecular Solutions Market
- 18.1. France Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Near-Patient Molecular Solutions Market
- 19.1. Italy Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Near-Patient Molecular Solutions Market
- 20.1. Spain Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Near-Patient Molecular Solutions Market
- 21.1. Eastern Europe Near-Patient Molecular Solutions Market Overview
- 21.2. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Near-Patient Molecular Solutions Market
- 22.1. Russia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Near-Patient Molecular Solutions Market
- 23.1. North America Near-Patient Molecular Solutions Market Overview
- 23.2. North America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Near-Patient Molecular Solutions Market
- 24.1. USA Near-Patient Molecular Solutions Market Overview
- 24.2. USA Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Near-Patient Molecular Solutions Market
- 25.1. Canada Near-Patient Molecular Solutions Market Overview
- 25.2. Canada Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Near-Patient Molecular Solutions Market
- 26.1. South America Near-Patient Molecular Solutions Market Overview
- 26.2. South America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Near-Patient Molecular Solutions Market
- 27.1. Brazil Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Near-Patient Molecular Solutions Market
- 28.1. Middle East Near-Patient Molecular Solutions Market Overview
- 28.2. Middle East Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Near-Patient Molecular Solutions Market
- 29.1. Africa Near-Patient Molecular Solutions Market Overview
- 29.2. Africa Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Near-Patient Molecular Solutions Market Competitive Landscape And Company Profiles
- 30.1. Near-Patient Molecular Solutions Market Competitive Landscape
- 30.2. Near-Patient Molecular Solutions Market Company Profiles
- 30.2.1. Bosch Healthcare Solutions GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 31. Near-Patient Molecular Solutions Market Other Major And Innovative Companies
- 31.1. Siemens Healthineers AG
- 31.2. Hologic Inc.
- 31.3. bioMérieux SA
- 31.4. Sysmex Corporation
- 31.5. QuidelOrtho Corporation
- 31.6. QIAGEN NV
- 31.7. DiaSorin SpA
- 31.8. OraSure Technologies Inc.
- 31.9. Molbio Diagnostics Pvt Ltd
- 31.10. Cue Health Inc.
- 31.11. Biocartis Group NV
- 31.12. Vela Diagnostics Pte Ltd
- 31.13. Co-Diagnostics Inc.
- 31.14. Hyris Ltd
- 31.15. Genedrive plc
- 32. Global Near-Patient Molecular Solutions Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Near-Patient Molecular Solutions Market
- 34. Recent Developments In The Near-Patient Molecular Solutions Market
- 35. Near-Patient Molecular Solutions Market High Potential Countries, Segments and Strategies
- 35.1 Near-Patient Molecular Solutions Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Near-Patient Molecular Solutions Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Near-Patient Molecular Solutions Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



